These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7507865)
1. Effects of recombinant human stem cell factor (rh-SCF) on colony formation and long-term bone marrow cultures (LTBMC) in patients with myelodysplastic syndromes. Soligo D; Servida F; Cortelezzi A; Pedretti D; Uziel L; Morgutti M; Pogliani E; Lambertenghi Deliliers G Eur J Haematol; 1994 Jan; 52(1):53-60. PubMed ID: 7507865 [TBL] [Abstract][Full Text] [Related]
2. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures. Lemoli RM; Gulati SC Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721 [TBL] [Abstract][Full Text] [Related]
3. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells. Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394 [TBL] [Abstract][Full Text] [Related]
4. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro. Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867 [TBL] [Abstract][Full Text] [Related]
6. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes. Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249 [TBL] [Abstract][Full Text] [Related]
7. The in vitro and in vivo effects of stem cell factor on human hematopoiesis. Hoffman R; Tong J; Brandt J; Traycoff C; Bruno E; McGuire BW; Gordon MS; McNiece I; Srour EF Stem Cells; 1993 Jul; 11 Suppl 2():76-82. PubMed ID: 7691331 [TBL] [Abstract][Full Text] [Related]
9. Responsiveness to stem cell factor (SCF) of peripheral blood colony-forming cells from patients with myelodysplastic syndromes (MDS). Masters GS; Baines P; Tang C; Bowen D; Burnett AK Leuk Res; 1995 Aug; 19(8):561-6. PubMed ID: 7544850 [TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells. Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323 [TBL] [Abstract][Full Text] [Related]
11. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes. Visani G; Tosi P; Finelli C; Gamberi B; Zauli G; Cenacchi A; Fogli M; Colombini R; Tura S Haematologica; 1992; 77(2):142-5. PubMed ID: 1383105 [TBL] [Abstract][Full Text] [Related]
12. Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodysplastic syndromes. Piacibello W; Sanavio F; Bresso P; Severino A; Carlesso N; Pregno P; Stacchini A; Morelli S; Fubini L; Gallo E Leukemia; 1994 Feb; 8(2):250-7. PubMed ID: 7508532 [TBL] [Abstract][Full Text] [Related]
13. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome. Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248 [TBL] [Abstract][Full Text] [Related]